Cargando…
Transferability of radiomic signatures from experimental to human interstitial lung disease
BACKGROUND: Interstitial lung disease (ILD) defines a group of parenchymal lung disorders, characterized by fibrosis as their common final pathophysiological stage. To improve diagnosis and treatment of ILD, there is a need for repetitive non-invasive characterization of lung tissue by quantitative...
Autores principales: | Gabryś, Hubert S., Gote-Schniering, Janine, Brunner, Matthias, Bogowicz, Marta, Blüthgen, Christian, Frauenfelder, Thomas, Guckenberger, Matthias, Maurer, Britta, Tanadini-Lang, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712180/ https://www.ncbi.nlm.nih.gov/pubmed/36465941 http://dx.doi.org/10.3389/fmed.2022.988927 |
Ejemplares similares
-
Applicability of radiomics in interstitial lung disease associated with systemic sclerosis: proof of concept
por: Martini, K., et al.
Publicado: (2020) -
Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis
por: Schniering, Janine, et al.
Publicado: (2022) -
Combined CT radiomics of primary tumor and metastatic lymph nodes improves prediction of loco-regional control in head and neck cancer
por: Bogowicz, Marta, et al.
Publicado: (2019) -
Radiomics Feature Activation Maps as a New Tool for Signature Interpretability
por: Vuong, Diem, et al.
Publicado: (2020) -
(18)F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease—A Proof-of-Concept Study
por: Schniering, Janine, et al.
Publicado: (2019)